Therapeutic Drug Monitoring Pipeline Report Highlights Development Phases, Clinical Trials, and Key Players in 2023
31 janv. 2024 03h57 HE
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Therapeutic Drug Monitoring Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023...
LifeArc makes multi-million pound investment to support drug discovery in sub-Saharan Africa
31 janv. 2024 02h00 HE
|
LifeArc
LifeArc makes multi-million pound investment to support drug discovery in sub-Saharan Africa LifeArc and the Bill & Melinda Gates Foundation are jointly investing £6 million ($7.2m) to enhance...
VBI-1901 Drug and Market Analysis Report 2023-2032: Mechanism of Action, Clinical Trials, Collaborations, and Market Projections for a Promising GBM Therapy
30 janv. 2024 10h59 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "VBI-1901 Emerging Drug Insight and Market Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This report provides an...
MGB-BP-3 Drug and Market Analysis 2023-2032: A Promising Treatment for Clostridium Difficile Infection (CDI)
30 janv. 2024 10h54 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "MGB-BP-3 Emerging Drug Insight and Market Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This report provides an...
MPH966 (Alvelestat) Drug Insight with Market Projections to 2032: A Novel Therapy Under Development for Bronchiolitis Obliterans Syndrome (BOS)
30 janv. 2024 10h51 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "MPH966 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers an in-depth...
MTG201 + Nivolumab Drug and Market Analysis 2023-2032: Sales Analytics, Clinical Assessment, SWOT Analysis, Emerging Competitors
30 janv. 2024 10h50 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "MTG201 + nivolumab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report provides...
Analysis of INOVIO's INO-5401 & INO-9012 and Regeneron & Sanofi's LIBTAYO (Cemiplimab) Treatment for Glioblastoma Multiforme (GBM): Drug Insights, Regulatory Landscape, and Market Forecast to 2032
30 janv. 2024 07h29 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "INO-5401 + INO-9012 + LIBTAYO Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This...
Analysis of AstraZeneca's IMFINZI (Durvalumab) for Treating Malignant Pleural Mesothelioma (MPM): Regulatory Landmarks, Market Expansion, Intellectual Property, Future Challenges - Forecast to 2032
30 janv. 2024 07h19 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "IMFINZI Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This comprehensive report...
Artificial Intelligence in Drug Delivery Market to Reach USD 13.6 Billion by 2033 from USD 1.2 Billion in 2023 | CAGR of 27.5%
30 janv. 2024 07h16 HE
|
Market.Us
New York, Jan. 30, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Global Artificial Intelligence in Drug Delivery Market size is forecasted to exceed USD 13.6 Billion by 2033, with a promising...
AV-GBM-1 Market Report 2023-2032: Drug Overview, Sales Analysis, SWOT Analysis, Emerging Competition and Future Prospects
30 janv. 2024 06h50 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "AV-GBM-1 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This market forecast report...